American Century Companies
TBIO

American Century Companies’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

American Century Companies’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-167,814
Closed -$4.62M – 2379
2021
Q2 		$4.62M Buy
167,814
+45,549
+37% +$895K ﹤0.01% 1004
2021
Q1 		$2.02M Buy
122,265
+86,763
+244% +$1.98M ﹤0.01% 1164
2020
Q4 		$654K Buy
+35,502
New +$635K ﹤0.01% 1438

American Century Companies's TBIO Position: Q3 2021 in Review

American Century Companies sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 167,814 shares — an estimated $4.62M sold.

American Century Companies first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $4.62M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • American Century Companies reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • American Century Companies sold 167,814 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $4.62M.
  • American Century Companies first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • American Century Companies's Translate Bio, Inc. Common Stock position peaked at $4.62M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on American Century Companies's 13F filing for Q3 2021, filed 10 Nov 2021.